Innovative Medicines Initiative Overview

  • Investor Type
  • Government

  • Status
  • Active

  • Professionals
  • 1

Professionals

  • Investments
  • 5

  • Portfolio
  • 1

  • Exits
  • 2

Exits

Innovative Medicines Initiative General Information

Company Description

Founded in 2008, Innovative Medicines Initiative is a public-private partnership between the European Union and the European pharmaceutical industry and is based in Brussels, Belgium. The firm seeks to invest in companies operating in the pharmaceuticals and biotechnology sectors.

Business Details

Year Founded
2008
Investor Status
Actively Seeking New Investments
Primary Investor Type
Government
Corporate Office
  • Avenue de la Toison d'Or 56-60
  • 1060 Brussels
  • Belgium
+32 02

Innovative Medicines Initiative Investments (5)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Novigenix 09-Apr-2025 Grant Decision/Risk Analysis Generating Revenue
Exvastat 15-May-2020 Drug Discovery Out of Business
BioVersys 29-Oct-2019 Drug Discovery Generating Revenue
Nosopharm 07-Nov-2013 Grant Drug Discovery Bankruptcy: Liquidation
Lipotype Grant Discovery Tools (Healthcare) Generating Revenue
To view Innovative Medicines Initiative’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innovative Medicines Initiative Exits (2)

Company Name Exit Date Exit Type Exit Size
Exvastat 07-Nov-2025 Out of Business
Nosopharm 22-Jun-2024
To view Innovative Medicines Initiative’s complete exits history, request access »

Innovative Medicines Initiative Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Innovative Medicines Initiative FAQs

  • What is Innovative Medicines Initiative?

    Founded in 2008, Innovative Medicines Initiative is a public-private partnership between the European Union and the European pharmaceutical industry and is based in Brussels, Belgium.

  • When was Innovative Medicines Initiative founded?

    Innovative Medicines Initiative was founded in 2008.

  • Where is Innovative Medicines Initiative headquartered?

    Innovative Medicines Initiative is headquartered in Brussels, Belgium.

  • How many investments has Innovative Medicines Initiative made?

    Innovative Medicines Initiative has made 5 investments.

  • What has Innovative Medicines Initiative invested in?

    Innovative Medicines Initiative has made numerous investments in companies like Novigenix, Exvastat, and BioVersys within the Decision/Risk Analysis and Drug Discovery industries.

  • What has Innovative Medicines Initiative invested in recently?

    Innovative Medicines Initiative's latest investment was on 09-Apr-2025 in Novigenix, a company within the Decision/Risk Analysis industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process